Items 321 to 330 of 414 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Illudin S | 1149-99-1 | sc-391575 sc-391575A | 1 mg 5 mg | $347.00 $1223.00 | 8 | |
Illudin S is a naturally occurring compound that demonstrates anticancer activity by disrupting cellular processes through its interaction with specific cellular targets. It is known to induce oxidative stress within cancer cells, leading to mitochondrial dysfunction and subsequent cell death. The compound's unique structural features facilitate its binding to critical biomolecules, enhancing its ability to modulate signaling pathways involved in cell survival and proliferation. Its reactivity and selectivity make it a subject of interest in the study of cancer biology. | ||||||
SF1126 | 936487-67-1 | sc-391584 sc-391584A | 5 mg 10 mg | $1050.00 $2240.00 | 7 | |
SF1126 is a synthetic compound that exhibits anticancer properties by selectively targeting and inhibiting key enzymes involved in tumor metabolism. Its unique structure allows for specific interactions with cellular receptors, disrupting critical signaling cascades that promote cancer cell growth. The compound's ability to induce apoptosis is linked to its modulation of reactive oxygen species levels, creating an unfavorable environment for tumor survival. Its kinetic profile suggests a rapid onset of action, making it a compelling subject for further investigation in cancer research. | ||||||
6-Des(diethanolamino)-6-chloro Dipyridamole | 54093-92-4 | sc-391628 | 10 mg | $330.00 | ||
6-Des(diethanolamino)-6-chloro Dipyridamole is a novel compound that demonstrates anticancer activity through its ability to modulate cellular pathways. It interacts with nucleic acids, potentially altering gene expression and disrupting the replication of cancer cells. The compound's unique halogen substitution enhances its reactivity, facilitating interactions with various biomolecules. Its distinct kinetic behavior suggests a targeted approach in cellular environments, warranting further exploration in cancer biology. | ||||||
Ginsenoside F2 | 62025-49-4 | sc-391654 sc-391654A | 1 mg 5 mg | $172.00 $312.00 | ||
Ginsenoside F2 exhibits anticancer properties by influencing key signaling pathways involved in cell proliferation and apoptosis. Its unique structure allows for specific interactions with cellular receptors, potentially modulating the activity of growth factors. This compound also demonstrates the ability to induce oxidative stress in cancer cells, leading to enhanced cell death. Additionally, Ginsenoside F2's distinct molecular dynamics may facilitate selective targeting of tumor microenvironments, highlighting its potential in cancer research. | ||||||
Pladienolide B | 445493-23-2 | sc-391691 sc-391691B sc-391691A sc-391691C sc-391691D sc-391691E | 0.5 mg 10 mg 20 mg 50 mg 100 mg 5 mg | $299.00 $5699.00 $11099.00 $25500.00 $66300.00 $2875.00 | 63 | |
Pladienolide B is a natural compound that disrupts the splicing of pre-mRNA, thereby influencing gene expression in cancer cells. Its unique ability to bind to the spliceosome complex alters the processing of oncogenes and tumor suppressor genes, leading to apoptosis in malignant cells. The compound's selective interaction with specific RNA motifs enhances its efficacy, while its distinct structural features contribute to its stability and reactivity in cellular environments, making it a subject of interest in cancer biology. | ||||||
Tabersonine | 4429-63-4 | sc-391702 sc-391702A sc-391702B | 10 mg 25 mg 100 mg | $320.00 $471.00 $1540.00 | ||
Tabersonine is an indole alkaloid that exhibits notable anticancer properties through its interaction with cellular signaling pathways. It modulates the activity of key enzymes involved in apoptosis and cell cycle regulation, promoting programmed cell death in neoplastic cells. Its unique structural conformation allows for selective binding to specific protein targets, influencing downstream signaling cascades. Additionally, Tabersonine's ability to disrupt microtubule dynamics further enhances its potential as a therapeutic agent in cancer research. | ||||||
1-Alaninechlamydocin | 141446-96-0 | sc-391717 | 500 µg | $208.00 | ||
1-Alaninechlamydocin is a novel compound that demonstrates anticancer activity by selectively inhibiting specific kinases involved in tumor proliferation. Its unique structural features facilitate strong interactions with target proteins, leading to altered phosphorylation states that disrupt critical signaling pathways. This compound also exhibits a distinctive ability to induce oxidative stress in cancer cells, promoting cellular damage and enhancing apoptotic responses. Its kinetic profile suggests a rapid onset of action, making it a compelling subject for further investigation in cancer biology. | ||||||
Albofungin | 37895-35-5 | sc-391725 | 1 mg | $292.00 | ||
Albofungin is a unique compound that exhibits anticancer properties through its ability to modulate cellular signaling pathways. It interacts with key regulatory proteins, leading to the disruption of cell cycle progression and apoptosis in malignant cells. Its distinct mechanism involves the generation of reactive oxygen species, which further exacerbates cellular stress. Additionally, Albofungin's stability and reactivity as an acid halide enhance its potential to form covalent bonds with biomolecules, influencing tumor microenvironment dynamics. | ||||||
Cellocidin | 543-21-5 | sc-391762 sc-391762A | 5 mg 25 mg | $100.00 $350.00 | ||
Cellocidin is a notable compound recognized for its anticancer activity, primarily through its selective targeting of tumor-associated enzymes. It engages in specific molecular interactions that inhibit critical pathways involved in cell proliferation and survival. By altering the redox state within cancer cells, Cellocidin promotes oxidative stress, leading to enhanced apoptosis. Its unique reactivity as an acid halide allows for the formation of stable adducts with biomolecules, potentially disrupting cancer cell metabolism and signaling. | ||||||
Hygrolidin | 83329-73-1 | sc-391768 sc-391768A sc-391768B sc-391768C | 1 mg 5 mg 10 mg 25 mg | $332.00 $1300.00 $1900.00 $3749.00 | ||
Hygrolidin exhibits remarkable anticancer properties by modulating key cellular signaling pathways. Its unique ability to interact with specific protein targets disrupts the balance of cell cycle regulation, promoting cell cycle arrest in malignant cells. Additionally, Hygrolidin's reactivity as an acid halide facilitates the formation of covalent bonds with nucleophilic sites in proteins, potentially altering their function and contributing to the induction of programmed cell death. | ||||||